Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey
Author(s) -
Gaëlle Francine Tchouwa,
Sabrina EymardDuvernay,
Amandine Cournil,
Nadine Lamare,
Laetitia Serrano,
Christelle Butel,
Silvia Bertagnolio,
Eitel MpoudiNgolé,
Elliot Raizes,
Avelin F. Aghokeng,
Sylvie Abia,
Dorothée Bessala,
Corneluis Chebo,
Oumarou Chifen,
John E Ebonloe,
Gaspary Fodjeu,
Suzanne Izard,
Brigitte Kamtie,
Emmanuel Kiawi,
Charles Kouam Kouam,
Charles Kouanfack,
E. Mamang,
Nadia Mandeng,
Eyongetah Mbu,
Bouba Mfokue,
Jembia Mosoko,
Bernard Nandjou,
Mireille Mpoudi,
Mariama Ndam,
Anne Esther Njom Nlend,
Batam Nlend,
Cecile Nouboué,
Pierrette Albertine Mbarga Omgba,
Thierry Owono,
Florant Oyono,
Calixte Ida Penda,
Xavier Tchetnya,
Christian Tchinou
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky221
Subject(s) - medicine , drug resistance , rural area , human immunodeficiency virus (hiv) , hiv drug resistance , demography , environmental health , family medicine , viral load , antiretroviral therapy , biology , pathology , sociology , microbiology and biotechnology
Pretreatment HIV drug resistance (PDR) has the potential to affect treatment outcome and mortality. We present here the first nationally representative PDR study conducted in Cameroon.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom